First Bank & Trust Bridge Bio Pharma, Inc. Transaction History
First Bank & Trust
- $505 Million
- Q4 2024
A detailed history of First Bank & Trust transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, First Bank & Trust holds 7,471 shares of BBIO stock, worth $237,278. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,471Holding current value
$237,278% of portfolio
0.04%Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
299Shares Held
171MCall Options Held
10.4MPut Options Held
2.33M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$802 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$798 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$479 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$395 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$193 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.71B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...